Menu
GWAS Study

Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer.

Lin Y, Nakatochi M, Hosono Y et al.

32581250 PubMed ID
GWAS Study Type
45453 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LY
Lin Y
NM
Nakatochi M
HY
Hosono Y
IH
Ito H
KY
Kamatani Y
IA
Inoko A
SH
Sakamoto H
KF
Kinoshita F
KY
Kobayashi Y
IH
Ishii H
OM
Ozaka M
ST
Sasaki T
MM
Matsuyama M
SN
Sasahira N
MM
Morimoto M
KS
Kobayashi S
FT
Fukushima T
UM
Ueno M
OS
Ohkawa S
EN
Egawa N
KS
Kuruma S
MM
Mori M
NH
Nakao H
AY
Adachi Y
OM
Okuda M
OT
Osaki T
KS
Kamiya S
WC
Wang C
HK
Hara K
SY
Shimizu Y
MT
Miyamoto T
HY
Hayashi Y
EH
Ebi H
KT
Kohmoto T
II
Imoto I
KY
Kasugai Y
MY
Murakami Y
AM
Akiyama M
IK
Ishigaki K
MK
Matsuda K
HM
Hirata M
SK
Shimada K
OT
Okusaka T
KT
Kawaguchi T
TM
Takahashi M
WY
Watanabe Y
KK
Kuriki K
KA
Kadota A
OR
Okada R
MH
Mikami H
TT
Takezaki T
SS
Suzuki S
YT
Yamaji T
IM
Iwasaki M
SN
Sawada N
GA
Goto A
KK
Kinoshita K
FN
Fuse N
KF
Katsuoka F
SA
Shimizu A
NS
Nishizuka SS
TK
Tanno K
SK
Suzuki K
OY
Okada Y
HM
Horikoshi M
YT
Yamauchi T
KT
Kadowaki T
YH
Yu H
ZJ
Zhong J
AL
Amundadottir LT
DY
Doki Y
IH
Ishii H
EH
Eguchi H
BD
Bogumil D
HC
Haiman CA
LM
Le Marchand L
MM
Mori M
RH
Risch H
SV
Setiawan VW
TS
Tsugane S
WK
Wakai K
YT
Yoshida T
MF
Matsuda F
KM
Kubo M
KS
Kikuchi S
MK
Matsuo K
Chapter II

Abstract

Summary of the research findings

Pancreatic cancer is the fourth leading cause of cancer-related deaths in Japan. To identify risk loci, we perform a meta-analysis of three genome-wide association studies comprising 2,039 pancreatic cancer patients and 32,592 controls in the Japanese population. Here, we identify 3 (13q12.2, 13q22.1, and 16p12.3) genome-wide significant loci (P < 5.0 × 10-8), of which 16p12.3 has not been reported in the Western population. The lead single nucleotide polymorphism (SNP) at 16p12.3 is rs78193826 (odds ratio = 1.46, 95% confidence interval = 1.29-1.66, P = 4.28 × 10-9), an Asian-specific, nonsynonymous glycoprotein 2 (GP2) gene variant. Associations between selected GP2 gene variants and pancreatic cancer are replicated in 10,822 additional cases and controls of East Asian origin. Functional analyses using cell lines provide supporting evidence of the effect of rs78193826 on KRAS activity. These findings suggest that GP2 gene variants are probably associated with pancreatic cancer susceptibility in populations of East Asian ancestry.

2,039 Japanese ancestry cases, 32,592 Japanese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

45453
Total Participants
GWAS
Study Type
Yes
Replicated
1,926 East Asian cases, 8,896 East Asian controls
Replication Participants
East Asian
Ancestry
Japan, U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.